Lyme News

Update on the Viral Genetics, Inc. (VRAL) Lyme drug program linked to previously. Reminder: IND means “Investigational new drug”, so Pre-IND is even earlier in the process.

We have recently entered into an agreement with a physician associated with one of the leading medical centers in the country to act as the “clinical lead” for this drug program. This doctor will complete the clinical portions of the pre-IND including an outline of the clinical trial protocol, as well as possibly serve as primary investigator for the planned clinical trial of our Lyme disease compound.